# A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects

> **NCT02140125** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 24 (actual)

## Conditions studied

- Healthy
- Pharmacokinetics of ASP2408

## Interventions

- **DRUG:** ASP2408
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02140125
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02140125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02140125, "A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02140125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*